OrthoPediatrics (NASDAQ:KIDS) Earns Buy Rating from Needham & Company LLC

OrthoPediatrics (NASDAQ:KIDS)‘s stock had its “buy” rating reaffirmed by analysts at Needham & Company LLC in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $42.00 price objective on the stock. Needham & Company LLC’s target price points to a potential upside of 68.00% from the stock’s previous close.

Separately, Truist Financial reduced their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th.

OrthoPediatrics Trading Up 2.3 %

NASDAQ KIDS opened at $25.00 on Tuesday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. OrthoPediatrics has a 52 week low of $21.02 and a 52 week high of $35.99. The stock’s 50 day moving average price is $24.20 and its two-hundred day moving average price is $27.41. The stock has a market capitalization of $605.40 million, a price-to-earnings ratio of -20.33 and a beta of 1.14.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Bank of New York Mellon Corp boosted its position in OrthoPediatrics by 14.9% during the second quarter. Bank of New York Mellon Corp now owns 68,700 shares of the company’s stock worth $1,976,000 after purchasing an additional 8,887 shares during the period. Rhumbline Advisers grew its position in OrthoPediatrics by 19.0% during the second quarter. Rhumbline Advisers now owns 26,613 shares of the company’s stock worth $765,000 after buying an additional 4,245 shares in the last quarter. Quest Partners LLC bought a new position in OrthoPediatrics during the 2nd quarter worth $34,000. American Century Companies Inc. raised its holdings in OrthoPediatrics by 63.0% in the 2nd quarter. American Century Companies Inc. now owns 15,669 shares of the company’s stock valued at $451,000 after acquiring an additional 6,059 shares in the last quarter. Finally, Divisadero Street Capital Management LP bought a new stake in OrthoPediatrics during the second quarter worth about $514,000. 69.05% of the stock is owned by institutional investors and hedge funds.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.